FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 1874852 · Received October 19, 2010

Report

Report Number
2124215-2010-17879
Event Type
Injury
Date Received
October 19, 2010
Date of Event
September 9, 2010
Report Date
September 9, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO AVAILABLE INFORMATION, THIS LEAD WAS REMOVED, REPLACED AND DISCARDED. NO RETURN OF PRODUCT IS INTENDED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS EVENT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT ONE MONTH POST IMPLANT, THIS ATRIAL LEAD DISPLAYED INCREASED THRESHOLD MEASUREMENTS AND LOSS OF CAPTURE. LEAD DISLODGEMENT WAS SUSPECTED. A REVISION PROCEDURE WAS PERFORMED, ATTEMPTS TO REPOSITION THE LEAD WERE UNSUCCESSFUL. THE LEAD WAS REMOVED AND REPLACED. NO LOSS OF THERAPY OCCURRED. THERE WAS NO ALLEGATION AGAINST THIS LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4096

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention